May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
The Role of ApoER2 Exon19 Splicing in Retinal Degeneration
Author Affiliations & Notes
  • M. Klein
    Rose Silverthorne Ret. Degen. Lab, Retina Foundation of the Southwest, Dallas, Texas
  • J. Herz
    Department of Molecular Genetics,
    UT Southwestern Medical Center, Dallas, Texas
  • J. Trotter
    Department of Molecular Genetics,
    UT Southwestern Medical Center, Dallas, Texas
  • D. G. Birch
    Rose Silverthorne Ret. Degen. Lab, Retina Foundation of the Southwest, Dallas, Texas
    Department of Ophthalmology,
    UT Southwestern Medical Center, Dallas, Texas
  • Footnotes
    Commercial Relationships  M. Klein, None; J. Herz, None; J. Trotter, None; D.G. Birch, None.
  • Footnotes
    Support  EY05235
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 2210. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Klein, J. Herz, J. Trotter, D. G. Birch; The Role of ApoER2 Exon19 Splicing in Retinal Degeneration. Invest. Ophthalmol. Vis. Sci. 2008;49(13):2210.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Very-low-density-lipoprotein receptor (VLDLR) and Apolipoprotein E Receptor 2 (ApoER2) are two receptors that bind Reelin, a protein which has been shown to have a vital role in neuronal development and adult synaptic plasticity. Absence of Reelin in Reeler mice leads to attenuated rod b-wave responses (Rice et al, Neuron, 9/2001) and loss of VLDLR results in choroidal neovascularization. ApoER2 is spliced in a diurnal fashion at exon19. The exon19 encoded insert plays a vital role in cell protection during normal aging and synaptic plasticity, but also facilitates cell death after injuries (Beffert et al, Neuron, 8/2005).To investigate the role of the ApoER2 exon19 splicing variant in retinal degeneration, electrophysiological testing was performed on knock-in mice that constitutively express ApoER2 with (+) or without (Δ) exon19.

Methods: : Ten month old ApoER2+exon19 (n=11), ApoER2Δexon19 (n=11), ApoER2+exon19/ VLDLR-/- (n=11) and ApoER2Δexon19/ VLDLR-/- (n=10) mutant mice, were tested and compared to age-matched wildtypes (WT, n=11).Full-field electroretinograms (ERG) were recorded on an Espion ERG system with Ganzfeld Dome, following standard ISCEV protocol adjusted for mice.

Results: : ApoER2+exon19/ VLDLR-/- mutants displayed the greatest reduction in amplitude in all responses (p<0.001). ApoER2+exon19 mice had attenuated rod responses and OPs (p<0.002).ApoER2Δexon19/ VLDLR-/- mutants showed smaller reductions in rod amplitude (p<0.005), but showed a slightly reduced cone flicker response (p=0.02). ApoER2Δexon19 mice were not significantly different from WT mice (p>0.1).

Keywords: electroretinography: non-clinical • retinal degenerations: cell biology • transgenics/knock-outs 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×